Successful dantrolene sodium treatment of a patient with myotonia congenita (Thomsen's disease).
A 3 year, 10 month old male with myotonia congenita (Thomsen's disease) was placed on dantrolene sodium, which successfully abolished the myotonic phenomenon. Dantrolene sodium might therefore be a useful medicine for patients with Thomsen's disease who do not respond to other medicines, such as carbamazepine (CBZ), with a decrease in the myotonic phenomenon.
Ohtaki
E
E
Department of Pediatrics and Child Health, Kurume University School of Medicine, Japan.
Komori
H
H
Yamaguchi
Y
Y
Matsuishi
T
T
D002675:Child, Preschool; D003620:Dantrolene / Q000627:therapeutic use*; D004576:Electromyography; D006801:Humans; D008297:Male; D009132:Muscles / Q000473:pathology / Q000503:physiopathology; D009224:Myotonia Congenita / Q000188:drug therapy* / Q000473:pathology; D012074:Remission Induction
D003620:Dantrolene